Compare Enbridge Inc (ENB) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enbridge Inc vs Nuwellis Inc — how do they compare? Enbridge Inc trades at $46.6 (market cap $103.38B), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: Enbridge Inc is far larger — about 46990.9× Nuwellis Inc's market cap, and Enbridge Inc pays a 6.02% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enbridge Inc for 91 Days and Nuwellis Inc for 26 Days on average.
| ENB | NUWE | |
|---|---|---|
Market Cap | $103.38B | $2.20M |
Volume | 3,684,305 | 121,544 |
Sector | Energy | Health |
52-Week High | $58.04 | $146.65 |
52-Week Low | $45.23 | $0.68 |
Typical Hold Time | 91 Days | 26 Days |
Enterprise Value | $185.39B | -$1.52M |
Dividend Yield | 6.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENB trades at $46.6, up 1.55% today, with a bearish technical signal but strong fundamental performance. The company reported revenue of $65.19B in 2025, with net income of $7.49B, and has beaten earnings estimates in recent quarters. Analyst consensus is mixed with a $61.63 price target, while recent news highlights its 6% dividend yield and growth in midstream and renewable energy assets.
Outlook remains balanced; ENB offers a stable dividend and EBITDA growth but faces headwinds from rising interest rates and high debt levels. Investment appeal hinges on execution of its $41B project backlog and ability to navigate energy market volatility, with risks including oil price fluctuations and leverage concerns.
NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.
While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
